We thank our funders, the Novo Nordisk ISS Scheme, the National Institute for Health Research (NIHR) UCL/UCLH Biomedical Research Centre and the Sir Jules Thorne Charitable Trust, for supporting our work
In a 12-week clinical study, obese participants taking 1 mg of AOD-9604 daily lost about 2.62.8 kg (56 lbs) on average more than triple the weight loss of the placebo group
Your PlexusDx clinician can provide personalized guidance based on your genetic profile and symptom report
Among frequent issues cited in the adverse event reports were administration of an extra or incorrect dose, issues with communication about a product, and prescribing errors
Hes in the gym five days a week and plays the drums with as much intensity as when he was 31
The Microdose Protocol delivers measurable appetite reduction and early weight loss results while minimizing nausea and GI side effects